Fact.MR – A Market Research and Competitive Intelligence Provider: The global bioprocess technology market was worth US$ 16.5 bn in 2020 and is forecast to reach US$ 78.8 bn by 2031, registering a CAGR of 14.8%.
Bioprocess Technology Applications in Biopharmaceuticals to Grow by 13.4% CAGR through 2031
The bioprocess technology market survey offers compelling insights into key factors impacting growth of the market through the assessment period from 2021 to 2031. The study also provides exhaustive analysis on hidden opportunities across various segments basis of type, application, and end user.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global bioprocess technology market was worth US$ 16.5 bn in 2020 and is forecast to reach US$ 78.8 bn by 2031, registering a CAGR of 14.8%. The report has projected North America to dominate the global market. The North America market value stood at US$ 5.4 bn in 2020.
As per Fact.MR, rising focus on discovery of alternative medicine will create opportunities for the growth of the market. Scope for application is expected to rise in response to rapid evolution in biotechnology and biopharmaceutical industries. Shift towards developing bio based products from biodegradable and fossil fuels also is creating opportunities for growth.
Rising cases of chronic diseases and chronic pain and consequent increase in demand for home monitoring devices will result in higher application of bioprocess technology. The market will witness improved scope for growth due to high demand for innovative drugs for sustained patient outcomes.
To remain ‘ahead’ of your competitors, request for a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6882
In terms of application, the demand for bioprocess technology in biopharmaceuticals will rise at a CAGR of 13.4% over the forecast period. Higher integration in research labs and hospitals will pave way for growth in the future. Cell culture bioprocess technology market will witness significant growth in the coming years.
“Application of bioprocess technology will pick up pace in response to surging production of biopharmaceuticals such as recombinant proteins and vaccines. Besides this, oligosaccharide manufacturing is expected to emerge as a rapidly growing field of bioprocess technology because of its various health benefits in treating chronic ailments,” says a Fact.MR analyst.
Key Takeaways
- The U.S. market is expected to register a CAGR of 12.1% and reach a valuation of US$ 26 bn through 2031.
- Demand for bioprocess technology in Germany will grow by 11.2% CAGR.
- Sales of bioprocess technology in India will grow by a CAGR of 19% through 2031.
- In terms of application, biopharmaceutical segment is anticipated to reach a valuation of US$ 490 bn through 2031.
Growth Drivers
- Surging adoption of cell culture bioprocess technology for studying basic cell biology and biochemistry will create scope for expansion.
- Increasing demand of bioprocess technology in hospitals and research labs are expected to bring lucrative sales opportunities for players operating in the global bioprocess technology market.
Ask Your Bioprocess Technology Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6882
Competitive Landscape
Leading players in the global bioprocess technology are investing in R&D, mergers, acquisitions, collaborations, and partnerships. They are also investing in product development and launches to stay ahead in the competition.
For instance, GE Healthcare acquired Puridify, a bioprocessing start up that aids in developing nanofiber based platform purification technology for producing biopharmaceutical in 2017.
Some of the key players operating in the global bioprocess technology as profiled by Fact.MR are:
- MilliporeSigma (Merck KGaA)
- Danher Life Sciences
- GE Healthcare (General Electric)
- Fujifilm Healthcare
- Catalent
- Lonza- Pharma & biotech
- CPC (Colder Products Co.)
- Thermo Fisher Scientific
- Sartorius Stedim Biotech
- Asahi Kasei Medical
- Boehringer Ingelheim
- Corning
- Eppendorf
- Repligen
- Solesis Medical (Fenner PLC)
- Dickinson and Company
- Bio-Rad Laboratories
- Charles River laboratories
More Insights on the Bioprocess Technology Market
Fact.MR provides an unbiased analysis of the bioprocess technology market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021 to 2031. The study divulges into compelling insights on the bioprocess technology market with detailed segmentation on the basis of:
Type
- Cell Culture
- Cell Expansion
- Flow Cytometry
- Cell Line Development
- Virus Infiltration
Application
- Biopharmaceuticals
- Specialty Products
- Industry Chemicals
- Environment Management Aid
End User
- Hospitals
- Research labs
- Medical Institutions
- Others
Regions
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East Africa
Key questions Covered in the Bioprocess Technology Market Report
- The report offers detailed insights into bioprocess technology demand outlook for 2021-2031
- The market study also highlights projected sales growth for bioprocess technology market between 2021 and 2031
- Bioprocess technology market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends, evaluation of current market size, and technological advancements within the industry
- Bioprocess technology market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Cell Lines Market Insights- Cell lines are employed in drug development, molecular biology, biochemistry, and cell biology, among other fields. The global cell lines market is affected by a number of benefits that cell lines provide, including ease of use, cost effectiveness, and the provision of pure cells, which are required for repeatable results and consistent samples. Furthermore, increasing technical improvements in the healthcare industry, new discoveries, and higher investment in research and development have resulted in the discovery of many cell line paradigms, propelling the global cell lines market forward.
Primary Cell Culture Market Research- The demand for primary cell culture is increasing as research into new treatments progresses. The demand for primary cell culture is also increasing as a result of research into the characterization and isolation of viruses. The market for primary cell culture products is being driven by an increase in academic life science research activities on tissue culture around the world. Aside from that, the rising frequency of chronic diseases such autoimmune diseases, cancer, diabetes, chronic infections, nephrological disorders, and cardiovascular diseases continues to be a lucrative avenue for primary cell culture product makers.
Flow Cytometry Market Analysis- Basic research, drug discovery, and clinical diagnostics all benefit from flow cytometry technology. In a number of clinical applications, such as blood diseases in medicine, flow cytometry is increasingly being utilized to detect many parameters simultaneously. As pharmaceutical and healthcare companies work to create advanced cancer diagnostics, the future prospects are likely to grow. As the COVID-19 pandemic raged, pharmaceutical companies pooled their resources to develop effective medication and vaccine compositions, a trend that kept flow cytometry in high demand well into 2020.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR